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Summary
Objective: To determine the best protocol for the preparation of a tissue-engineered cartilage to investigate the potential anti-arthritic and/or
anti-osteoarthritic effects of drugs.
Methods: Calf articular chondrocytes, seeded in collagen sponges were grown in culture for up to 1 month. At day 14 cultures received
interleukin (IL)-1b (ranging from 0.1 to 20 ng/ml) for 1 to 3 days. Analyses of gene expression for extracellular matrix proteins, collagen-binding
integrins, matrix metalloproteinases (MMPs), aggrecanases, TIMPs, IL-1Ra and Ik-Ba were carried out using real-time polymerase chain re-
action (PCR). Metalloproteinase activities were analysed in the culture medium using both zymography and ﬂuorogenic peptide substrates.
Results: We selected a culture for 15 or 17 days with collagen sponges seeded with 107 chondrocytes showing a minimal cell proliferation,
a maximal sulphated glycosaminoglycan (sGAG) deposition and a high expression of COL2A1, aggrecan and the a10 integrin sub-unit and
low expression of COL1A2 and the a11 integrin sub-unit. In the presence of 1 ng/ml IL-1b, we observed at day 15 up-regulations of 450-fold for
MMP-1, 60-fold for MMP-13, 54-fold for ADAMTS-4 and MMP-3 and 10-fold for ADAMTS-5 and IL-1Ra. Down-regulations of 2.5-fold for
COL2A1 and aggrecan were observed only at day 17. At the protein level a dose-dependent increase of total MMP-1 and MMP-13 was noted
with less than 15% in the active form.
Conclusions: This in vitro model of chondrocyte culture in three dimensional (3D) seems well adapted to investigate the responses of these
cells to inﬂammatory cytokines and to evaluate the potential anti-inﬂammatory effects of drugs.
ª 2006 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Several studies have demonstrated the important role
played by inﬂammatory cytokines such as interleukin-1
(IL-1a and IL-1b) or tumour necrosis factor a (TNF-a) in me-
diating the cartilage degradation observed in rheumatoid ar-
thritis (RA) and osteoarthritis (OA)1e3. The in vitro activation
of cultured chondrocytes by IL-1 is associated with dramatic
changes in the expression of a large number of genes that
contribute to cartilage degradation. For example IL-1 stimu-
lates the synthesis of several matrix metalloproteinases
(MMPs) and other inﬂammatory cytokines and inhibits the
production of key extracellular matrix proteins such as
type II collagen and aggrecan4,5.
In order to investigate the potential anti-arthritic and/or
anti-osteoarthritic effects of drugs and to obtain information
on their mechanism of action, it is important to culture chon-
drocytes within microenvironments as close as possible to
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Received 27 April 2005; revision accepted 13 January 2006.6in vivo conditions and without major changes in their carti-
lage phenotype. Stimulated by the ﬁrst clinical results of car-
tilage defect repair by the transplantation of human
autologous chondrocytes, reported by Brittberg et al.6, sev-
eral tissue-engineered cartilages have been prepared with
isolated chondrocytes grown within various three-dimen-
sional (3D) scaffolds. Synthetic (e.g. poly[DL-lactic-co-
glycolic acid]) or natural (agarose, alginate, hyaluronan,
chitosan and collagen) polymers have been seeded with
differentiated or dedifferentiated chondrocytes or with mesen-
chymal stem cells (MSCs), under different culture conditions
in order to select the best protocol for the clinical repair of
partial- or full-thickness articular cartilage defects7e13.
In our laboratory, we chose to seed freshly isolated bo-
vine articular chondrocytes into collagen-based 3D matrices
in the form of sponges14e16 or gels17. We compared the in-
ﬂuence of different culture parameters (static, stirred or per-
fusion conditions; presence of 10% foetal calf serum (FCS)
or serum-free media supplemented with ITS (insulin, trans-
ferrin, selenium) and cysteine16; absence of fresh ascorbic
acid in the culture medium15) on the composition and prop-
erties of reconstituted cartilage under long-term culture (up
to 3 months). In order to characterise the mechanism of ac-
tion of a symptomatic acting drug in OA (Avocado/Soybean31
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in vitro reconstituted articular cartilage using bovine chon-
drocytes activated or not by an inﬂammatory cytokine. In
this ﬁrst paper we describe the best protocol selected to
test the activation of chondrocytes by IL-1 and their re-
sponse at the gene and protein level. Articular chondrocytes
from young calves, easily available in large numbers, were
seeded at two initial cell densities into collagen sponges
and cultured for 15 or 30 days. Under these conditions, ma-
trix deposition and density remain low, thereby permitting
easy access of the active molecules to cells even in the
centre of the construct20. To investigate the effects of IL-1
(0.1e20 ng/ml from day 14 for 1 or 3 days) on chondrocyte
behaviour, we determined gene expression by using real-
time reverse transcriptase polymerase chain reaction (RT-
PCR) for several bovine genes coding for (1) matrix proteins
(type I and II collagens, aggrecan), (2) collagen receptor in-
tegrin sub-units (a1, a2, a10, a11), (3), MMP-1, -2, -3, -13
and aggrecanases (ADAMTS-4, -5), and (4) TIMP-1, -2 (tis-
sue inhibitor metalloproteinase) and proteins involved in the
IL-1 signalling pathway (IL-1Ra, Ik-Ba). At the protein level
we measured the active and inactive forms of collagenases
1 and 3 (MMP-1 and MMP-13), using speciﬁc ﬂuorogenic
substrates and gelatinases A and B (MMP-2 and MMP-9)
using zymography.
Materials and methods
CELL CULTURE
Collagen sponges, manufactured by Coletica (Lyon,
France), were composed of collagen extracted from the
skin of young calves containing 90e95% (dry weight) of na-
tive type I collagen and 4e9% type III collagen. In this study,
6 mm thick sponges were cross-linked using the carbodii-
mide method21 to increase their stability. In brief, collagen
sponges (9 8 cm) were incubated for 30 min in a 2-mor-
pholinoethane sulphonic acid buffer (MES, Fluka, St Quen-
tin Fallavier, France) in ethanol/water (40% v/v) (50 mM, pH
5.5) (400 ml/g). Cross-linking was carried out in the same
buffer containing 14 mM N-[3-dimethylaminopropyl]-N 0-
ethylcarbodiimide hydrochloride (EDC) and 8 mM N-
hydroxy-succinimide (NHS) (Accros, Noissy Le Grand,
France). The reaction was performed at room temperature
for 4 h. After removal of the cross-linking solution, samples
were incubated for 2 h in sodium phosphate (0.1 M, pH 8.8).
Finally the matrices were washed successively with 1 M
NaCl and 2 M NaCl for 2 h (with ﬁve changes of washing
solution), respectively, followed by washing with distilled
water for 1 day and lyophilisation. Individual discs were
cut out with a 10 mm diameter punch before being sterilised
with 15 kGy b radiation. Such sponges, after sterilisation,
exhibited thermal transition temperatures of 39(C (onset)
and 48(C (peak) as measured by differential scanning cal-
orimetry (Symate`se biomate´riaux, Chaponost, France).
Freshly isolated chondrocytes (day 0) were obtained by
enzymatic digestion of cartilage from the metacarpophalan-
geal joints of 6-month-old calves and 106 and 107 cells were
seeded onto each sponge placed in a 24-well culture plate,
as previously described14,15. Two hours after seeding, 2 ml
of culture medium [RPMI/NCTC (v/v) (Sigma) containing
10% FCS (Biochrom KG, Berlin, Germany), 50 U/ml penicil-
lin, 50 mg/ml streptomycin and 1 ng/ml amphotericin] were
added to each well and the plates were further incubated
at 37(C and 5% CO2. Two days later, the sponges were
cultured in 12.5 cm2 culture ﬂasks (three sponges in 15 ml
of culture medium) and placed on a Polymax 1040 orbitalshaker (30 rpm). As the drug to be tested in this model is
soluble in ethanol, we checked the inﬂuence of this solvent
added in the culture medium at a concentration of 0.2%. At
day 14, some sponges were grown in serum-free medium
containing rHu IL-1b (PromoKine, Heidelberg, Germany)
at 0.1, 0.25, 0.5, 1, 5 and 20 ng/ml for 1 or 3 days. The me-
dium was replaced every day during the whole culture.
CELL PROLIFERATION AND GAG CONTENT
The amount of DNA was measured using Hoechst 33258
dye and cell numbers were calculated based on the known
DNA content per chondrocyte of 7.8 pg14. The sulphated
glycosaminoglycan (sGAG) content in the sponges was de-
termined spectrophotometrically using a modiﬁed dimethyl-
methylene blue method and shark chondroitin sulphate as
a standard14. In all cases, three samples were analysed per
condition in three independent experiments. The sGAG
content was also measured in the culture medium of one ex-
periment. In brief, themedia of treated cultureswere collected
and pooled every 3 days for up to 15 or 30 days of treatment.
Each sample (45 ml) was freeze-dried and re-suspended
with 5 ml 10 mM Tris HCl buffer, pH 8 before papain (Sigma)
digestion (6 mg/ml in 10 mM Tris HCl, 1 mMCaCl2) for 2 h at
60(C. Then, the samples were dialysed against water for 2
days at 4(C before measurement of the sGAGs.
GENE EXPRESSION ANALYSIS
Total RNA was isolated from the chondrocyte-seeded
collagen sponges with the RNeasy kit (Qiagen, Courta-
boeuf, France) and digested with DNase to remove any
contaminating genomic DNA. Reverse transcription of
0.5 mg total RNA was carried out under conditions previ-
ously described15.
For real-time PCR, the reaction contained 10 ml of IQ
SYBR green supermix (Biorad, Marnes la Coquette,
France), 4 ml of 1/3 diluted RT in sterilised water, 1 ml of
each primer at 0.3 mM and 4 ml water. Following an initial
step of 1 min at 95(C and a denaturation step of 2 min at
95(C, fragments were ampliﬁed with n cycles of denatur-
ation (95(C, 15 s), annealing/elongation for 30 s using
primers speciﬁcally designed for this application (Table I).
Ampliﬁcation was performed in an iCycler IQ (Biorad). The
PCR efﬁciencies of ampliﬁcation (at threshold level¼ 200)
for the studied genes ranged from 90 to 110%. For each
cDNA sample the Ct value of the reference gene L30
22
was subtracted from the Ct value of the target sequence
to obtain the DCt. The level of expression was then
calculated as 2DCt and expressed in relative quantity/L30
(RQ/L30) as the meanSD of three or six samples in three
experiments. In this work relative changes equal to or
greater than 2-fold were considered as biologically signif-
icant. All the PCR ampliﬁed products were puriﬁed for iden-
tiﬁcation by sequence analysis (Genome express, Meylan,
France). L30 was used to verify that equal amounts of
RNA were added to the reaction. Differences in gene ex-
pression were analysed just after collection of the chondro-
cytes (day 0) and at 14þ 1 and 14þ 3 days of culture.
ANALYSIS OF MMP-1, -2, -9 AND -13 IN CULTURE MEDIUM
OF CHONDROCYTES TREATED OR NOT WITH IL-1b
To assay metalloproteinase activities as described23,24,
50 ml of conditioned media, collected at day 15 or 17 was
incubated for 1 h in 440 ml Tris HCl buffer containing
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Genes Forward and reverse primers (50e30) Product size (bp) Annealing temperature ((C) References
MMP-2 GGGGAGATTCCCACTTTGAT 138 57 NM174745
TGCAGCTGGTGTACTCCTTG
MMP-3 TGGACCTGGAAAAGTTTTGG 178 59 AF135232
AGCTTCACGTTCGGTTGAGT
ADAMTS-4 CTCCATGACAACTCGAAGCA 169 59 NM181667
CTAGGAGACAGTGCCCGAAG
ADAMTS-5 CACCTCAGCCACCATCACAG 152 59 AF192771
AGTACTCTGGCCCGAAGGTC
IL-1Ra CTCCAGAGATGCCTGTCCAC 106 59 AB005148
CCAGGGCTCTTGTACCTCCT
Ik-Ba TACTCCCCGTACCAGCTCAC 114 59 AJ420928
GCTCTCCTCATCCTCGCTCT
TIMP-1 CACCCACAGACGGCCTTCT 90 60 AF144763
CTGGTATAAGGCAGTTTCATTGACTT
TIMP-2 TGGGTCACGGAGAAGAACATC 71 60 AF144764
GAGCCGTCGCTTCTCTTGAT200 mM NaCl and 5 mM CaCl2. The buffers were prepared
at 125 mM and 100 mM for MMP-1 and MMP-13, respec-
tively. To measure total MMP (active MMPþ proMMP)
5 mg/ml trypsin (Sigma) was added for the activation of
proMMP. The active MMP level was measured in the sam-
ple not incubated with trypsin. To stop the reaction, 10 ml of
trypsin inhibitor (50 mg/ml) (Sigma) was added to the sam-
ples and incubated for 15 min at RT. Finally the speciﬁc
ﬂuorogenic substrates [(DNP-Pro-Cha-Abu-Cys(Me)-
His-Ala-Lys(N-Me-Abz)-NH2] for MMP-1 at 5 mM and
[MCA-Pro-Cha-Gly-Nva-His-Ala-Dpa-NH2] for MMP-13 at
8 mM (Calbiochem, Strasbourg, France) were added to the
reaction vial and 2 aliquots of 200 ml were added to individ-
ual wells in a 96-well plate. The plate was further incubated
for 4 h at 37(C and the ﬂuorescence read in an FLX-800
Bio-Tek Instrument at Ex/Em 365 nm/450 nm for MMP-1
and 325 nm/393 nm for MMP-13. A control corresponding
to the medium collected from non-seeded sponges was
also analysed.
Gelatinase activity was measured by gelatin-substrate
zymography as previously described15 using the culture
medium from chondrocytes seeded in collagen sponges
and grown with 1, 5 or 20 ng/ml IL-1b for 1 or 3 days in me-
dium without serum. Thirty microlitre samples of medium
collected after 24 or 72 h of treatment were mixed with 4
Laemmli’s non-reducing loading buffer and subjected to
electrophoresis in 10% polyacrylamide gels containing
0.1% gelatin. After electrophoresis, the gels were treated
as previously published15.
STATISTICAL ANALYSIS
The statistical signiﬁcance of quantitative parameters
was assessed using a Student’s t-test.
Results
CALF CHONDROCYTES CULTURED IN COLLAGEN SPONGES:
CELL PROLIFERATION AND sGAG DEPOSITION
First, in order to determine the best experimental condi-
tions to check the effect of IL-1b on chondrocytes, we com-
pared the cell proliferation and sGAG deposition of calf
articular chondrocytes seeded in collagen sponges at two
initial cell densities (106 and 107 cells/sponge) and cultured
for 15 and 30 days. As shown in Fig. 1(A, B), a 6e7-fold in-
crease in cell numbers after 15 and 30 days of culture wasobserved in sponges initially seeded with 106 cells (A),
whereas cell numbers remained unchanged, in sponges
seeded with 107 cells (B) after 15 and 30 days (11 106
and 9 106 cells, respectively). In all cases no signiﬁcant
differences in cell content were observed in culture media
with or without 0.2% ethanol.
As shown in Fig. 1(C, D), the sGAG content of sponges
seeded with 106 (C) and 107 (D) cells were 106 and
170 mg/sponge, respectively, after 15 days in culture and
150 and 180 mg/sponge, respectively, after 30 days. In
one set of experiments (107 cells/sponge) we measured
(not shown) the total sGAG secreted in the medium. After
15 and 30 days in culture the values obtained were 750
and 1100 mg/sponge, respectively. If compared to the
sGAG content present in the sponges at the same time
(around 180 mg/sponge) it appears that after 15 days
more than 82% of the sGAG are secreted in the medium
and more than 86% after 30 days.
In all cases no signiﬁcant differences were observed in
sGAG content in sponge or in culture media with or without
0.2% ethanol. A slight contraction (15% of their initial diam-
eter) of the sponges seeded with 106 or 107 cells was ob-
served after 15 days, without modiﬁcation after 30 days.
From these data, we selected for the rest of the study
a culture for 15 days of sponges initially seeded with 107
calf chondrocytes. Under these conditions cell multiplication
was minimal and sGAG deposition was maximal whereas
the addition of 0.2% ethanol in the medium was without ef-
fect on these parameters.
GENE EXPRESSION OF CALF CHONDROCYTES, IN 3D
CULTURE, TREATED OR NOT BY IL-1b
Real-time PCR (Figs. 2e5) was used to quantify and
compare the expression of the genes coding for collagen
types I (a2 chain) and II (a1 chain), aggrecan, integrin
sub-units a1, a2, a10 and a11, MMP-1, -2, -3 and -13,
ADAMTS-4 and -5, TIMP-1 and -2 and for two molecules
involved in the IL-1b signalling pathway, IL-1Ra and Ik-Ba.
The following conditions were analysed: freshly isolated
cells (day 0) and after 15 and 17 days in culture without
IL-1b (open bars in Figs. 2e5) and after IL-1b treatment
at day 14 for 1 and 3 days (grey bars in Figs. 2e5). For
all the genes studied the addition of 0.2% ethanol in the
medium did not modify their expression at day 15 (as
shown by comparison of the open bars noted 0 and 0/þ
in Figs. 2e5).
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Fig. 1. Cell number and sGAG content of bovine chondrocytes seeded in collagen sponges. One (A and C) or ten million (B and D) cells were
initially seeded in sponges and grown throughout the culture in serum supplemented medium (10% FCS) containing or not 0.2% ethanol. Cell
numbers were quantiﬁed by measuring the DNA content of the sponges after 15 and 30 days (A and B) of culture. sGAG content was mea-
sured using a colorimetric method with dimethylmethylene blue after 15 and 30 days (C and D). Data are presented as the mean S.E.M. of
triplicate samples obtained from three independent experiments.Collagen II
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Fig. 2. Effect of the presence of IL-1b on the expression of cartilage
matrix speciﬁc genes, when added on day 14 to 107 bovine chon-
drocytes seeded in collagen sponges. Cultures were grown in
serum-free medium for 1 or 3 days containing IL-1b at 0.1, 0.25,
0.5, 1, 5, 20 ng/ml and 0.2% ethanol. Control cultures received or
not 0.2% ethanol noted 0/þ and 0. RNAs were extracted from
sponges followed by real-time PCR as described in Materials and
methods. The amount of mRNA obtained was normalised to the
amount of L30. Results are expressed in relative quantity/L30
(RQ/L30) SD from three experiments carried out with three to
six samples. Comparisons were performed using the Student’s
t-test: **, P< 0.01; ***, P< 0.001).As Fig. 2 shows, a decrease in the expression of COL2A1
(around 20-fold) and aggrecan (around 6.5-fold) and an in-
crease in the COL1A2 expression (10-fold) were observed
after 15 and 17 days of culture. As a consequence the rela-
tive expression ratio of COL2A1/COL1A2, as high as 2550
for the freshly isolated chondrocytes (day 0), reached 12.5
and 10 after 15 and 17 days of culture, respectively. How-
ever type II collagen remained the main collagen expressed
under these culture conditions. In the presence of IL-1b,
a signiﬁcant decrease in expression of aggrecan was ob-
served after 1 day of culture and with a concentration
5 ng/ml and after 3 days of culture for COL2A1 and aggre-
can (concentration 1 ng/ml) and for COL1A2 (concentra-
tion  5 ng/ml). Interestingly the relative ratio of the
expression level of COL2A1/COL1A2 remained similar.
In Fig. 3, we compared the expression of a1, a2, a10 and
a11 integrin sub-unit genes. In freshly isolated chondro-
cytes we detected low levels of a10 (8 103/L30) and
a1 (3 103/L30) and very low levels of a2 (7 104/
L30) and a11 (1.5 104/L30) integrin sub-unit mRNAs.
After 15 days of culture the a1 integrin sub-unit mRNA level
increased (7.5-fold) whereas it decreased for the a2 and
a10 sub-units (24- and 9-fold, respectively). The level of
expression of the a11 sub-unit was not changed. After treat-
ment for 1 day with 1 or 5 ng/ml IL-1b the expression of
these genes were not signiﬁcantly changed.
Figure 4 shows the gene expression level of four metallo-
proteinases (MMP-1, -2, -3 and -13) and aggrecanases-1
and -2 (ADAMTS-4 and -5). In freshly isolated cells the ex-
pression of the MMP-2 and MMP-3 genes was similar and
at a relatively high level (8 102/L30) whereas for the
other genes expression was very low: 2 103/L30 for
ADAMTS-5, 9 104/L30 for MMP-13 and ADAMTS-4
and only 4 105/L30 for MMP-1. After 15 days of culture
the variations were not very large.
In the presence of IL-1b, with the exception of the MMP-2
gene, all the other genes presented dose-dependent and
signiﬁcant increases in their expression. After 1-day treat-
ment, a signiﬁcant increase (between 4- and 9-fold) was
ﬁrst obtained with 0.5 ng/ml IL-1b. With 1 ng/ml IL-1b the
expression levels reached a plateau with increases as
high as 450-fold for MMP-1, 60-fold for MMP-13, 54-fold
for ADAMTS-4 and MMP-3 and 10-fold for ADAMTS-5.
After 3 days of culture, a dose-dependent increase was
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Fig. 3. Effect of the presence of IL-1b on the expression of collagen receptor integrin sub-unit genes, when added on day 14 to 107 bovine
chondrocytes seeded in collagen sponges. Cultures were grown in serum-free medium for 1 day containing IL-1b at 1 and 5 ng/ml and 0.2%
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**, P< 0.01; ***, P< 0.001.also observed for these genes, the highest levels being
obtained with 20 ng/ml IL-1b for MMP-3 (8/L30), MMP-1
(0.5/L30), MMP-13 (0.36/L30), ADAMTS-5 (0.2/L30) and
ADAMTS-4 (0.016/L30).The levels of expression of the TIMP-1 and TIMP-2
genes are shown in Fig. 5: similar levels were observed in
freshly isolated cells (0.09/L30 and 0.15/L30, respectively),
values only slightly increased after 15 days of culture. AfterMMP-1
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Fig. 5. Effect of the presence of IL-1b on the expression of TIMP-1 and -2 and IL-1Ra and Ik-Ba genes, when added on day 14 to 107 bovine
chondrocytes seeded in collagen sponges. Cultures were grown in serum-free medium for 1 or 3 days containing IL-1b at 0.1, 0.25, 0.5, 1, 5,
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pressed in relative quantity/L30 (RQ/L30) SD from three experiments carried out with three to six samples. Comparisons were performed
using the Student’s t-test: **, P< 0.01; ***, P< 0.001.1-day treatment with IL-1b, a slight dose-dependent in-
crease was noted for the TIMP-1 gene (3-fold with 20 ng/
ml), whereas the level of expression of the TIMP-2 gene
was not signiﬁcantly changed.
For the interleukin-1 receptor antagonist protein gene
(IL-1Ra), a very low level of expression was detected in
freshly isolated cells and after 15 days of culture (104/
L30), whereas a signiﬁcant increase was observed in the
presence of IL-1b with a maximum (20-fold) after 3 days
with 20 ng/ml IL-1b (Fig. 5). For Ik-Ba, a net decrease
(10- and 6-fold) in the expression was noted after 15
and 17 days of culture, respectively (Fig. 5), when com-
pared to the value obtained with freshly isolated chondro-
cytes (day 0). In the presence of IL-1b, a dose-dependent
increase in the expression level was shown to reach, with
20 ng/ml IL-1b, the level obtained with freshly isolated
cells.
MMP-1, -2, -9 AND -13 PROTEIN LEVEL AND ACTIVITY
In order to conﬁrm, at the protein level, the data obtained
at the gene expression level we used zymography for the
analysis of MMP-2, -9 and -13 [Fig. 6(A, B)] and speciﬁc ﬂu-
orogenic substrates for MMP-1 and MMP-13 [Fig. 6(CeF)].
Zymography performed on the serum-free medium after
15 or 17 days of culture demonstrated the presence of
MMP-2, more than 95% of which was in the inactive
proMMP-2 form and the absence of MMP-9 and MMP-13.
In the presence of increasing doses of IL-1b and notably af-
ter 3 days of treatment, it was possible to show an increase
in the amount of proMMP-2 and to detect bands corre-
sponding to proMMP-9, MMP-2 and proMMP-13.
Cleavage of the two speciﬁc ﬂuorogenic peptides by me-
dia non-treated with trypsin measured the amount of the
active forms of MMP-1 and MMP-13 [Fig. 6(C, E)],
whereas, after trypsin treatment, both proMMP and MMP
forms were measured, noted here as total MMP [Fig. 6(D,
F)]. After 15 and 17 days the values obtained for both ac-
tive and total forms of MMP-1 and MMP-13, present in
the medium, were very low, at the limit of detection of the
method. In the presence of IL-1b, large dose-dependentincreases in these values for both MMP-1 and MMP-13
were observed after 1 and 3 days. For example [Fig. 6(C,
D)] after 1 day with 20 ng/ml IL-1b, 6- and 18-fold increases
in the amounts of the active and total forms of MMP-1, re-
spectively, were noted. For both MMP-1 and MMP-13, the
active forms corresponded to less than 15% of the total
forms.
Discussion
In this study we present a model culture system that facil-
itated the exposure of chondrocytes to catabolic stimulators
such as IL-1b and could be used for the determination of the
metabolic responses of the cells in the presence of com-
pounds with anti-inﬂammatory potential.
The choice of calf chondrocytes isolated from the meta-
carpophalangeal joint of 6-month-old animals was dictated
by the easy access to the tissue and the large amount of
cells available (more than 100 106 cells/joint). In our pre-
vious paper using the same cells17 we have shown that
the mRNA levels of the genes studied here were not very
different for chondrocytes present in native cartilage or iso-
lated after matrix release (noted here as the freshly isolated
cells). Furthermore for more than ten experiments using
cells isolated from different animals of the same age, we
have always obtained reproducible levels of expression
for most of the genes studied. For example, as expected
for differentiated chondrocytes, high levels of COL2A1,
COL9A1, aggrecan and a10 integrin sub-unit mRNAs and
very low levels of COL1A2 and a11 integrin sub-unit
mRNAs were measured in all the native cartilage extracts
and the freshly isolated cells17.
After a high initial cell-seeding density (107 cells) in colla-
gen sponges, the cell number remained unchanged after 15
days of culture, whereas the sGAG content (170 mg/
sponge) demonstrated the neoformation of a cartilage-like
extracellular matrix. Furthermore as the extracellular matrix
deposition, depending on the culture duration as previously
shown16 remained low under these conditions, the con-
struct had a high diffusivity, necessary for optimal molecular
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than chondrocytes in native cartilage20.
After 15 days of culture within the collagen sponge, in spite
of a decrease in COL2A1 and an increase in COL1A2
expression when compared to freshly isolated cells, the
COL2A1/COL1A2 ratio remained high (12.5) demonstrating
that the cells still expressed a cartilage-like phenotype.
These results are consistent with the high expression of
the aggrecan and a10 integrin sub-unit genes and the low
expression of the a11 integrin sub-unit gene. We conﬁrm
here our previous data obtained with the same chondrocytes
cultured in monolayer or within type I collagen gels17 show-
ing that the ratio of COl2A1/COl1A2 chain mRNA levels
varied as the ratio of the a10/a11 integrin sub-unit mRNAs,
depending on the differentiation/dedifferentiation state of
the chondrocytes. This result is in good accordance with
the non-overlapping expression pattern of a10b1 (cartilage)
and a11b1 (non cartilaginous tissues) integrins25,26. It is thus
important to note that in our model the main collagen-binding
integrins expressed are a1b1 and a10b1 whereas the
expression of a2b1 and a11b1 integrins was very low.
In the presence of high doses of IL-1b and after 3 days of
treatment there were signiﬁcant decreases in the expres-
sion of COL2A1 and aggrecan (1 ng/ml) and COL1A2
(5 ng/ml) as previously shown for chondrocytes in mono-
layer27,28 or alginate bead culture29. The COL2A1/
COL1A2 expression ratio had not changed with these
treatments.Concerning the expression of gene markers of matrix
degradation, at day 0 (freshly isolated cells) and after 15
or 17 days of culture, the order of decreasing mRNA level
of most metalloproteinases is the following: MMP-
3¼MMP-2>ADAMTS-5>ADAMTS-4¼MMP-13>MMP-1.
It is interesting to note that Bau et al.30 obtained the same
order of mRNA levels for these enzymes for chondrocytes
present in human articular cartilage (from donor ages
40e83 years). Important differences appear after culture
in vitro: we have observed in our model (15 days of culture
within a collagen sponge) only a very slight increase in the
expression of these genes, whereas Bau et al.30 observed
very strong induction of the same genes (190e1000-fold)
after 2 days of culture in alginate beads or in high-density
monolayer. Further addition of 1 ng/ml IL-1b in their cultures
did not lead to a great induction of the metalloproteinase
genes (less than 10-fold for MMP-1 or MMP-13). In our
model we observed a dose-dependent induction with IL-
1b of all these genes with the exception of MMP-2. Signiﬁ-
cant increases started after 1 day with 0.5 ng/ml IL-1b. With
1 ng/ml and at 1 day we observed very large induction
(54e450-fold for ADAMTS-4 and MMP-1, -3, and -13 and
10-fold for ADAMTS-5). Even higher expression of these
genes was obtained with the highest dose of IL-1b used
(20 ng/ml) and the longest treatment time (3 days),
corresponding to the following order of decreasing
mRNA expression levels: MMP-3>MMP-1>MMP-13>
ADAMTS-5> ADAMTS-4.
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aggrecanase 2 (ADAMTS-5) is more highly expressed
(>10-fold) than aggrecanase 1 (ADAMTS-4). Recent
data31,32 have shown that ADAMTS-5 was the major aggre-
canase in mouse cartilage in vivo and in vitro and that the
ADAMTS-5 null mice are protected from joint destruction
in a model of OA (surgically induced joint instability) and
in a model of experimental inﬂammatory arthritis. In hu-
mans, as in our bovine model, ADAMTS-5 is expressed at
higher levels than ADAMTS-4 in both normal and arthritic
cartilage30,33 . However, further work will be required to de-
termine the exact role played by these two enzymes during
the progression of OA in human.
In contrast to the preceding enzymes analysed, the
expression of MMP-2 was notable in the freshly isolated
chondrocytes and after 15 days of culture and was not up-
regulated by IL-1b as previously shown inmonolayer cultures
of human34 and rabbit chondrocytes35 or human tendon
cells36.
For MMP-1 and MMP-13, we conﬁrmed, at the protein
level, their large and dose-dependent induction by IL-1b us-
ing ﬂuorogenic substrate assays. As the values measured
without IL-1b were within the detection limits of this method,
it was difﬁcult to quantify the increase in the inactive and ac-
tive forms of MMP-1 and MMP-13. However, with or without
IL-1b, the ratio between the active (MMP) and inactive
(proMMP) forms of MMP-1 and MMP-13 had not changed
(less than 15% of the enzymes were present in the culture
medium in the active form).
Furthermore by using zymography we were only able to
detect with the highest dose of IL-1b (20 ng/ml) and after
3 days a slight increase in proMMP-2 and the presence of
faint bands on the zymogram corresponding to proMMP-9,
MMP-2 and proMMP-13.
As a ﬁrst attempt to determine the signalling pathway in-
volved in the increased expression of MMPs and ADAMTSs
by IL-1b in our model, we measured the expression of two
important genes coding for the IL-1Ra and for an inhibitor of
NF-kB activity (Ik-Ba). IL-1Ra prevents the interaction be-
tween IL-1 and its cell surface receptor and thus competi-
tively inhibits the pro-inﬂammatory activities of IL-137.
Recombinant human IL-1Ra has recently been approved
for use in patients with RA38. In our culture model we ob-
served a net, dose-dependent increase in the expression
of IL-1Ra in the presence of IL-1b. We thus conﬁrm here,
as previously reported with human articular chondrocytes
in monolayer culture39,40, that IL-1Ra production might be
part of a negative feedback mechanism initiated by IL-1.
Inﬂammatory responses induced by IL-1b are largely co-
ordinated by NF-kB, a complex group of heterodimeric and
homodimeric transcription factors. These molecules are
trapped by Ik-Ba in the cytoplasm as an inactive complex41.
Indeed, blocking NF-kB activity by the overexpression of Ik-
Ba, a member of the Ik-B family, reduces inﬂammation and
tissue destruction by MMP-1 and MMP-3 in rheumatoid sy-
novial tissue and dermal ﬁbroblasts42,43. Here we measured
the expression level of Ik-Ba, and showed that its expres-
sion by freshly isolated chondrocytes (day 0) largely de-
creased after 15 or 17 days of culture without IL-1b,
whereas in the presence of IL-1b, a dose-dependent and
signiﬁcant increase in its expression was observed, reach-
ing its initial value (day 0) for 20 ng/ml IL-1b. It is obvious
that these increases in both IL-1Ra and Ik-Ba gene expres-
sions are not sufﬁcient to counteract the activity of NF-kB as
high increases of MMPs gene expression are measured af-
ter only 24 h treatment with IL-1b and concentration equal or
higher than 0.5 ng/ml. However, for concentration 1 ng/ml3 days treatments are necessary, in our model, to signiﬁ-
cantly decrease the expression of COL2A1 and aggrecan
genes. It is worth noting that in OA and RA patients, con-
centrations of IL-1b measured in synovial ﬂuids averaged
0.028 ng/ml and 0.1 ng/ml, respectively44,45.
This culture model is currently used to check the effect of
drugs such as ASU and their active fractions as well as mol-
ecules whose ability to antagonize the IL-1-stimulated cata-
bolic activity of chondrocytes was previously demonstrated
using different in vitro chondrocyte culture models46e48 .
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